ReviewCureus2026
Facial Nerve Palsy With Olfactory and Gustatory Dysfunction Following COVID-19 Infection: An Illustrative Case-Based Narrative Review.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
COVID-19 infection has been recognized to induce a wide range of neurological manifestations, ranging in severity from transient, benign manifestations to severe neurological deficits. Cranial nerve involvement, particularly facial, olfactory, and gustatory nerve dysfunction, has emerged as a notable clinical feature in affected individuals. This review article aims to present and analyze three confirmed COVID-19 diagnoses that exhibited facial nerve palsy (FNP), olfactory disturbances (OD), and/or gustatory disturbances (GD), while also exploring the potential underlying pathophysiological mechanisms of these symptoms. This article presents three cases of laboratory-confirmed COVID-19 in which patients developed FNP along with OD and/or GD, and discusses their potential pathophysiological mechanisms. All three patients had hallmark signs and symptoms of FNP, with dysgeusia present in three and anosmia present in two. COVID-19 was confirmed with reverse transcription polymerase chain reaction (RT-PCR) testing. Neuroimaging and cerebrospinal fluid analysis ruled out other differential diagnostic possibilities. Treatment strategies varied from case to case and included steroids, antivirals, and traditional medicine. Outcomes ranged from partial to complete recovery of FNP within four weeks. The three presented cases suggest a temporal association between COVID-19 and FNP, though case reports alone cannot establish causation. While direct neural invasion, immune response, or ischemic injury are potential mechanisms, a definitive cause has not yet been established. OD and GD in the presented cases were short-lived, which may suggest, but cannot confirm, a mechanism different from direct cranial nerve involvement. This remains speculative given the small sample size. Further research is warranted to elucidate the pathophysiology of cranial nerve involvement, thereby guiding diagnosis and treatment strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.